Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alyson Chapman"'
Autor:
Kyuhan Lee, Shakthi Gunasinghe, Alyson Chapman, Lynne A. Findlow, Jody Hyland, Sheetal Ohol, Andrea Urwin, Martin K. Rutter, Jonathan Schofield, Hood Thabit, Lalantha Leelarathna
Publikováno v:
Biosensors, Vol 11, Iss 11, p 457 (2021)
Flash glucose monitoring (FGM) and real-time continuous glucose monitoring (RT-CGM) are increasingly used in clinical practice, with improvements in HbA1c and time in range (TIR) reported in clinical studies. We aimed to evaluate the impact of FGM an
Externí odkaz:
https://doaj.org/article/2ef86de035a34cff94019bb89f5ec5ae
Autor:
Bilal Bashir, Panchami Elisaus, Viktoria Chatzimavridou Grigoriadou, Andrea Urwin, Alyson Chapman, Sheetal Ohol, Lynne Ann Findlow, Jody Foster, Rachel Harwood, Catherine Fullwood, Jonathan Schofield, Martin K. Rutter, Lalantha Leelarathna, Hood Thabit
Publikováno v:
Diabetic medicine : a journal of the British Diabetic AssociationREFERENCES. 39(5)
Autor:
Alyson Chapman, Lalantha Leelarathna, Sheetal Ohol, Jody Hyland, Kyuhan Lee, Jonathan Schofield, Martin K. Rutter, Shakthi Gunasinghe, Andrea Urwin, Lynne A Findlow, Hood Thabit
Publikováno v:
Lee, K, Gunasinghe, S, Chapman, A, Findlow, L A, Hyland, J, Ohol, S, Urwin, A, Rutter, M K, Schofield, J, Thabit, H & Leelarathna, L 2021, ' Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes—Findings from a Large UK Centre ', Biosensors, vol. 11, no. 11, pp. 457 . https://doi.org/10.3390/bios11110457
Biosensors
Volume 11
Issue 11
Biosensors, Vol 11, Iss 457, p 457 (2021)
Biosensors
Volume 11
Issue 11
Biosensors, Vol 11, Iss 457, p 457 (2021)
Flash glucose monitoring (FGM) and real-time continuous glucose monitoring (RT-CGM) are increasingly used in clinical practice, with improvements in HbA1c and time in range (TIR) reported in clinical studies. We aimed to evaluate the impact of FGM an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194a09b545ba40a8661db8c4593076c2
https://www.mdpi.com/2079-6374/11/11/457
https://www.mdpi.com/2079-6374/11/11/457
Autor:
Pushpa Jinadev, Martin K. Rutter, Lalantha Leelarathna, Andrea Urwin, Alyson Chapman, Tayiba Alam, Hood Thabit, Konstantinos Markakis, Andrew J.M. Boulton
Publikováno v:
Markakis, K, Alam, T, Jinadev, P, Chapman, A, Urwin, A, Thabit, H, Boulton, A J M, Rutter, M K & Leelarathna, L 2019, ' Continuous Subcutaneous Insulin Infusion Initiation Is Associated With Blood Pressure Reduction in Adults With Type 1 Diabetes ', Journal of Diabetes Science and Technology, pp. 1932296818822818 . https://doi.org/10.1177/1932296818822818, https://doi.org/10.1177/1932296818822818
Background: In type 1 diabetes (T1D) continuous subcutaneous insulin infusion (CSII) use has been associated with lower risks for mortality and diabetes-related complications when compared to multiple daily injections. There are limited data on the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04efb1bede1b36e142c28590c3cbd5a2
https://doi.org/10.1177/1932296818822818
https://doi.org/10.1177/1932296818822818